Answers are grounded in this paper and cite their sources.
Rheumatic diseases are traditionally treated using symptomatic drugs (NSAIDs -Nonsteroidal Anti-Inflammatory Drugs) and specific drugs. Nevertheless, the inhibitory effect of traditional NSAIDs, caused by both types of COX enzymes, besides easing inflammation and pain, also has a number of damaging effects on gastric mucosa protection mechanisms. Therefore, NSAIDs administration is also contraindicated in patients who suffered or are suffering from chronic liver or kidney disease, or in patients on anticoagulants.
No takes yet. Share an insight, caveat, or question.
Ls et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: